Results 181 to 190 of about 268,538 (298)

Management of Proteinuria in Dogs and Cats with Chronic Kidney Disease [PDF]

, 2016
Atkins, Bakris, Bianchi, Bomback, Brown, Brown, Brown, Brown, Bugbee, Christ, Finco, Grauer, Grauer, Horita, Jacob, Jenkins, Jepson, Jepson, Jonathan Elliott, King, King, Laverman, Lees, Lefebvre, LeVine, Linas, Littman, Maack, McAlister, Mizutani, Nabity, Nakamura, Pollock, Pressler, Ryan, Schjoedt, Schneider, Segev, Segev, Sent, Shelly L. Vaden, Singh, Syme, Tenhundfeld, Toblli, Vaden, Wehner   +46 more
core   +1 more source

A Meta-Analysis of the Impact of Using Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin II Receptor Blockers (ARBs) on Mortality, Severity, and Healthcare Resource Utilization in Patients with COVID-19. [PDF]

Adv Respir Med
Li R, Zhang J, Ren L.
europepmc   +1 more source

Relationship between in-hospital angiotensin converting enzyme inhibitors and Angiotensin receptor blockers administration and delirium in the cardiac ICU. [PDF]

Hosp Pract (1995), 2023
Mulkey MA, Hauser PHP, Aucoin J.
europepmc   +1 more source

Disparate Effects of Angiotensin Converting Enzyme Inhibitor and Calcium Blocker Treatment on the Preservation of Renal Structure and Function Following Subtotal Nephrectomy or Streptozotocin-Induced Diabetes in the Rat

, 1987
B. Jackson, R. Cubela, L. Debrevi, M. Whitty, C. I. Johnston   +4 more
openalex   +1 more source

Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke. [PDF]

J Am Heart Assoc
Chang KC, Lin CH, Huang JA.
europepmc   +1 more source

Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction. [PDF]

PLoS One, 2023
Chen CW, Chang CW, Lin YC, Chen WT, Chien LN, Huang CY.   +5 more
europepmc   +1 more source

PGY2 Ambulatory Care Pharmacy Resident [PDF]

Objectives: 1. Explain the screening, diagnosis, and pathophysiology of diabetic nephropathy 2. Describe the renin-angiotensin-aldosterone system (RAAS) and the mechanism of action and effects of angiotensin-converting enzyme inhibitors (ACE-I) and ...
Carrie Rogers Pharm. D
core  

Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients. [PDF]

Heliyon, 2023
Mekary W, Fares S, Abdulhai F, Massoud G, Refaat M, Mericskay M, Booz GW, Zouein FA.   +7 more
europepmc   +1 more source

Hemodynamic Effects of Angiotensin-Converting Enzyme Inhibitors in Essential Hypertension

, 1985
M. A. Fitzpatrick, Stevo Julius
openalex   +1 more source

Role of Bradykinin in Anaphylactoid Reactions during Hemodialysis with AN69 Dialyzers [PDF]

, 1993
Barkhausen, Regina, Fink, Edwin, Heidland, August, Kulzer, Peter, Schaefer, Liliana, Schaefer, Roland M.   +5 more
core   +1 more source